BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 37663818)

  • 1. Efficacy and safety of therapeutic procedure for Waldenström's macroglobulinemia with hyperviscosity syndrome.
    Ito K; Kawasaki T; Hirano K; Sekiguchi N
    Ther Apher Dial; 2024 Jun; 28(3):417-423. PubMed ID: 38069574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New developments in the diagnosis and characterization of Waldenström's macroglobulinemia.
    García-Sanz R; Hunter ZR; Poulain S; Varettoni M; Owen RG
    Expert Rev Hematol; 2023; 16(11):835-847. PubMed ID: 37905549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Survival in a Patient With Transformation of Waldenström's Macroglobulinemia into DLBCL.
    Solia E; Ntanasis-Stathopoulos I; Kastritis E; Terpos E; Dimopoulos MA; Gavriatopoulou M
    Cancer Diagn Progn; 2024; 4(1):77-80. PubMed ID: 38173665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Waldenstrom's macroglobulinemia associated with Hodgkin's lymphoma: a case report.
    Fu Y; Zhu H; Liu P
    J Biomed Res; 2013 Jun; 29(6):508-11. PubMed ID: 26273017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapsed Waldenstrom's Macroglobulinemia and Therapy-Related Myelodysplastic Syndrome with Complex Cytogenetics: A Treatment Dilemma.
    Kalantri S; Singh I; Yang L; Abuelgasim KA
    Case Rep Oncol; 2023; 16(1):351-356. PubMed ID: 37384207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogammopathy Maculopathy Secondary to Waldenström's Macroglobulinemia Complicated With Diabetic Retinopathy: A Case Report and Literature Review.
    Ogata N; Ueda K; Aoki S
    Cureus; 2023 Jul; 15(7):e41622. PubMed ID: 37565119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal gammopathy of renal significance: An atypical presentation of Waldenström's disease.
    Rodríguez-Doyágüez P; Motornaya-Morozova ; Martínez-Miguel P; Castillo-Torres C; Toldos-González Ó; Gil-Fernández JJ
    Clin Nephrol Case Stud; 2024; 12():17-21. PubMed ID: 38352852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candidate genes of Waldenström's macroglobulinemia: current evidence and research.
    Bianchi G; Sacco A; Kumar S; Rossi G; Ghobrial I; Roccaro A
    Appl Clin Genet; 2013; 6():33-42. PubMed ID: 23935380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudothrombus deposition accompanied with minimal change nephrotic syndrome and chronic kidney disease in a patient with Waldenström's macroglobulinemia: A case report.
    Mwamunyi MJ; Zhu HY; Zhang C; Yuan YP; Yao LJ
    World J Clin Cases; 2019 Aug; 7(16):2393-2400. PubMed ID: 31531336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment with bortezomib for refractory fever associated with myelodysplastic syndrome with underlying lymphoplasmacytic lymphoma.
    Motomura Y; Umezawa Y; Arimatsu T; Okada K; Miura O; Kumagai T
    Clin Case Rep; 2022 Feb; 10(2):e05372. PubMed ID: 35154721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematologic secondary malignancies among 102 Chinese patients with Waldenstrom's macroglobulinemia: a single-center case experience and literature review.
    Wang L; Xi C; Huang Y; Xu H; Miao Y; Cheng Y
    Front Oncol; 2023; 13():1280033. PubMed ID: 38090491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA expression in tumor cells from Waldenstrom's macroglobulinemia reflects both their normal and malignant cell counterparts.
    Hodge LS; Elsawa SF; Grote DM; Price-Troska TL; Asmann YW; Fonseca R; Gertz MA; Witzig TE; Novak AJ; Ansell SM
    Blood Cancer J; 2011 Jun; 1(6):e24. PubMed ID: 22829168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to Move to the Single-Cell Level: Applications of Single-Cell Multi-Omics to Hematological Malignancies and Waldenström's Macroglobulinemia-A Particularly Heterogeneous Lymphoma.
    García-Sanz R; Jiménez C
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33810569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An advanced case of Waldenström's macroglobulinemia complicated by acquired hemophilia a in a patient with neurofibromatosis type 1.
    Dybko Z; Jodłowski G; Borkowski A; Giordano U; Sawicki M; Dybko J
    Pol Arch Intern Med; 2024 Apr; ():. PubMed ID: 38661676
    [No Abstract]   [Full Text] [Related]  

  • 15. There's life in the old dog yet: immunochemotherapy in Waldenström's macroglobulinemia.
    Kastritis E; Buske C
    Leukemia; 2024 Mar; ():. PubMed ID: 38454119
    [No Abstract]   [Full Text] [Related]  

  • 16. Editor's Note: Eph-B2/Ephrin-B2 Interaction Plays a Major Role in the Adhesion and Proliferation of Waldenstrom's Macroglobulinemia.
    Azab F; Azab AK; Maiso P; Calimeri T; Flores L; Liu Y; Quang P; Roccaro AM; Sacco A; Ngo HT; Zhang Y; Morgan BL; Carrasco RD; Ghobrial IM
    Clin Cancer Res; 2024 Feb; 30(4):920. PubMed ID: 38362727
    [No Abstract]   [Full Text] [Related]  

  • 17. Waldenström's macroglobulinemia with necrotic extremities: A case with challenging diagnosis.
    Nekooghadam SM; Ghadirzadeh E; Lapevandani MM; Ghorbani P; Yazdi YG; Shafiei S; Rakhshan A; Paraandavaji E; Charkazi E
    Clin Case Rep; 2023 Sep; 11(9):e7809. PubMed ID: 37663818
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.